Pathology News

David Rimm, MD, PhD, Anthony N. Brady Professor of Pathology, professor, medicine, Medical Oncology, Yale School of Medicine; director, Physician Scientist Training Program, Pathology Research, director, Tissue Microarray Facility, director, Yale Pathology Tissue Services, Pathology, Yale Cancer Center, discusses the primary challenges in distinguishing between HER2-low and HER2-ultralow breast cancer using current immunohistochemistry diagnostic kits.

The Association for Diagnostics & Laboratory Medicine (formerly AACC) celebrates outstanding contributions to medicine through its annual awards program, which culminates with formal recognition at the the Association for Diagnostics & Laboratory Medicine (ADLM) Annual Scientific Meeting.

A foundation started by Joseph Madri, MD, PhD, professor emeritus of pathology, and his wife, Lucille, funds many worthwhile causes, including a professorship at the Yale Department of Pathology.

Getting older can affect the heart, kidneys, and other important organs, leading to health problems and a decreased quality of life. Although aging is a natural process that every living person goes through, little is known about what causes our bodies to age. Daniel Jane-Wit, MD, PhD, associate professor of medicine (cardiovascular medicine) and immunobiology, is investigating what causes our bodies to age and how we might be able to one day block or slow this process.

A story in CAP Today on how rapid autopsies are bridging the gap between clinical care and research features Harry Sanchez, MD, Assistant Professor of Pathology, and Marcello DiStasio, MD, PhD, Assistant Professor of Pathology. Dr. Sanchez and Dr. DiStasio are Co-Directors of the Yale Legacy Tissue Donation Program.

On June 12 – 13, 2024, Yale Cancer Center and Smilow Cancer Hospital hosted the annual Lung Cancer SPORE Workshop at Yale West Campus. This year’s two-day workshop was held in commemoration of the 20th anniversary of the discovery of the epidermal growth factor receptor (EGFR) mutation in lung cancer, which launched the era of personalized medicine in advanced non-small cell lung cancer (NSCLC), leading to a dramatic shift in treatment.

An enzyme engineered by Yale researchers prevented lupus in mice and shows promise for human patients with the disease.

Synder was honored for his “important and sustained contributions to our community” as a leader of the blood bank and transfusion medicine as well as grant review panels.

Yale Cancer Center scientists and trainees attended the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago May 31-June 4 to present research advances from Yale Cancer Center and Smilow Cancer Hospital. The ASCO meeting is the most significant gathering of oncology professionals worldwide, initiating connections and forging collaborations that can change the landscape of cancer care.